A106190 Stock Overview
Researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 5/6 |
Dividends | 1/6 |
Rewards
Risk Analysis
No risks detected for A106190 from our risk checks.
High Tech Pharm Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩14,330.00 |
52 Week High | ₩16,850.00 |
52 Week Low | ₩7,880.00 |
Beta | 0.89 |
1 Month Change | 17.46% |
3 Month Change | 58.17% |
1 Year Change | 69.79% |
3 Year Change | 34.34% |
5 Year Change | 48.24% |
Change since IPO | 55.76% |
Recent News & Updates
There's Reason For Concern Over High Tech Pharm Co., Ltd.'s (KOSDAQ:106190) Massive 25% Price Jump
May 09Is High Tech Pharm (KOSDAQ:106190) A Risky Investment?
Apr 23Recent updates
There's Reason For Concern Over High Tech Pharm Co., Ltd.'s (KOSDAQ:106190) Massive 25% Price Jump
May 09Is High Tech Pharm (KOSDAQ:106190) A Risky Investment?
Apr 23We Think High Tech Pharm (KOSDAQ:106190) Has A Fair Chunk Of Debt
Feb 23Did High Tech Pharm's (KOSDAQ:106190) Share Price Deserve to Gain 91%?
Jan 19What Is The Ownership Structure Like For High Tech Pharm Co., Ltd. (KOSDAQ:106190)?
Dec 15Shareholder Returns
A106190 | KR Pharmaceuticals | KR Market | |
---|---|---|---|
7D | -11.0% | -1.4% | -1.7% |
1Y | 69.8% | 2.7% | 0.6% |
Return vs Industry: A106190 exceeded the KR Pharmaceuticals industry which returned 2.7% over the past year.
Return vs Market: A106190 exceeded the KR Market which returned 0.6% over the past year.
Price Volatility
A106190 volatility | |
---|---|
A106190 Average Weekly Movement | 7.0% |
Pharmaceuticals Industry Average Movement | 4.2% |
Market Average Movement | 5.1% |
10% most volatile stocks in KR Market | 11.3% |
10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A106190's share price has been volatile over the past 3 months.
Volatility Over Time: A106190's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1998 | n/a | Jeong-Soo Kim | www.htpharm.com |
High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea.
High Tech Pharm Co., Ltd. Fundamentals Summary
A106190 fundamental statistics | |
---|---|
Market cap | ₩152.37b |
Earnings (TTM) | ₩11.60b |
Revenue (TTM) | ₩82.54b |
13.1x
P/E Ratio1.8x
P/S RatioIs A106190 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A106190 income statement (TTM) | |
---|---|
Revenue | ₩82.54b |
Cost of Revenue | ₩65.40b |
Gross Profit | ₩17.14b |
Other Expenses | ₩5.55b |
Earnings | ₩11.60b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.09k |
Gross Margin | 20.77% |
Net Profit Margin | 14.05% |
Debt/Equity Ratio | 15.3% |
How did A106190 perform over the long term?
See historical performance and comparison